On December 8, 2025, Wave Life Sciences will unveil interim data from its Phase 1 INLIGHT trial, focusing on WVE-007, a promising treatment for obesity. This article explores the trial's significance, ...

All cells need to sense and respond to their environment, to know when to activate genes, build proteins, and carry out their ...

All cells need to sense and respond to their environment, to know when to activate genes, build proteins, and carry out their ...

Preclinical in vivo data demonstrate hyper-precise mechanism directly targets the disease-causing mRNA repeats leading to correction of splicing ...

Shares of Arcturus Therapeutics ARCT have plunged 59.4% in the past three months. The massive stock price drop was primarily ...

Ribosomes, the protein factories of the cell, are essential for all living organisms. They bind to mRNA and move along the ...

A collaborative study by scientists at the University of California, Riverside, and University of Southern California reports ...

LMU researchers uncover the mechanism by which ribosomes raise alarms in the cell. Ribosomes, the protein factories of the cell, are essential for all living organisms. They bind to mRNA and move ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this ...

National Key Laboratory for Pig Genetic Improvement and Germplasm Innovation, Ministry of Science and Technology, Jiangxi Agricultural University, Nanchang, China N6-methyladenosine (m6A) is the most ...

Moderna, an mRNA specialist known for its COVID-19 vaccine Spikevax, is winding down development of three clinical mRNA programs, including two investigational vaccines for infectious diseases. The ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...